Universe Pharmaceuticals annual operating margin
2019
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals's operating margin was −16.33% for fiscal 2025.
View full Universe Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-09-30 | −16.33% | +18.50 pp |
| 2024 | 2024-09-30 | −34.83% | +12240.80 pp |
| 2023 | 2023-09-30 | −12,275.63% | −12258.14 pp |
| 2022 | 2022-09-30 | −17.49% | −45.81 pp |
| 2021 | 2021-09-30 | 28.32% | −5.07 pp |
| 2020 | 2020-09-30 | 33.39% | +4.04 pp |
| 2019 | 2019-09-30 | 29.35% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Over the last five reported fiscal years, Universe Pharmaceuticals's operating margin decreased from 33.39% to −16.33%, a change of −49.72 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals filings at SEC.gov ↗